临床外科杂志 ›› 2025, Vol. 33 ›› Issue (12): 1271-1275.doi: 10.3969/j.issn.1005-6483.20241519

• 论著 • 上一篇    下一篇

血清甲状腺球蛋白抗体、促甲状腺素水平与分化型甲状腺癌病人临床病理特征的相关性及对术后转移的预测价值

刘雅琳 梁金屏 马旭   

  1. 063000 河北唐山,唐山市人民医院头颈肝胆科(刘雅琳、马旭) ,头颈科(梁金屏)
  • 收稿日期:2024-09-14 出版日期:2025-12-20 发布日期:2025-12-20

The correlation between serum TgAb and TSH levels and clinical pathological features of differentiated thyroid cancer patients,and their predictive value for postoperative metastasis

LIU Yalin,LIANG Jinping,MA Xu   

  1. Department of Head and Neck Hepatology,Tangshan People's Hospital,Tangshan 063000,China
  • Received:2024-09-14 Online:2026-01-22 Published:2025-12-20

摘要: 目的 探讨血清甲状腺球蛋白抗体(TgAb)、促甲状腺素(TSH)水平与分化型甲状腺癌(DTC)病人临床病理特征的相关性及对术后转移的预测价值。方法 2022年6月~2023年6月治疗的103例DTC病人为癌变组,根据病人是否发生术后转移分为转移组(26例)和未转移组(77例);同期103例甲状腺良性病变病人为对照组。比较血清TgAb、TSH的水平;多因素Logistic回归分析DTC病人发生术后转移的影响因素;ROC曲线分析血清TgAb、TSH水平对DTC病人发生术后转移的预测价值。结果 对照组TgAb、TSH水平分别为(54.65±6.68)IU/ml,(1.24±0.36)mIU/L,癌变组分别为(110.56±13.42 )IU/ml,(5.28±1.73)mIU/L,两组比较差异有统计学意义(P<0.05);低分化、TNM分期为Ⅲ+Ⅳ期、肿瘤浸润病人血清TgAb、TSH水平高于中高分化、TNM分期为Ⅰ+Ⅱ期、无肿瘤浸润病人,差异有统计学意义(P<0.05);与未转移组比较,转移组血清TgAb、TSH水平以及低分化、肿瘤浸润的占比均明显升高,差异有统计学意义(P<0.05);TgAb、TSH为DTC病人发生术后转移的影响因素(P<0.05);血清TgAb、TSH水平预测DTC病人发生术后转移的曲线下面积(AUC)分别为0.778、0.756, 二者联合预测的AUC为0.889,二者联合预测的AUC明显高于单一指标预测(Z二者联合-TgAb=2.200、Z二者联合-TSH=1.950,P=0.028、0.046),二者联合预测的敏感度为76.81%,特异性为94.81%。结论 DTC病人血清TgAb、TSH水平均明显上调,TgAb、TSH水平变化与临床病理特征存在一定联系,二者联合对病人发生术后转移具有较高的预测价值。

关键词: 分化型甲状腺癌; 甲状腺球蛋白抗体; 促甲状腺素; 临床病理特征; 术后转移

Abstract: Objective To investigate the correlation between serum thyroid globulin antibody (TgAb),thyroid stimulating hormone (TSH) levels and clinical pathological features of differentiated thyroid cancer (DTC) patients,and their predictive value for postoperative metastasis.Methods From June 2022 to June 2023,103 DTC patients treated in our hospital were included as the diseased group.They were separated into a metastasis group (26 cases) and a non metastasis group (77 cases) based on whether they had postoperative metastasis.Another 103 patients with benign thyroid lesions were included as the control group.The levels of TgAb and TSH in serum were compared.Multivariate Logistic regression was applied to analyze the influencing factors of postoperative metastasis in DTC patients.ROC curve was applied to analyze the predictive value of serum TgAb and TSH levels for postoperative metastasis in DTC patients.Results Compared with the control group[(54.65±6.68)IU/ml,(1.24±0.36)mIU/L],the serum TgAb and TSH levels in the cancer group[(110.56±13.42)IU/ml,(5.28±1.73)mIU/L)] were significantly increased (P<0.05).Patients with low differentiation,TNM stage Ⅲ+Ⅳ,and tumor infiltration had obviously higher levels of serum TgAb and TSH than patients with medium to high differentiation,TNM stage Ⅰ+Ⅱ,and no tumor infiltration (P<0.05).Compared with the non metastasis group,the serum TgAb and TSH levels,and the proportions of low differentiation and tumor infiltration were obviously higher in the metastasis group (P<0.05).TgAb and TSH were influencing factors for postoperative metastasis in DTC patients (P<0.05).The area under the curve (AUC) for predicting postoperative metastasis in DTC patients based on serum TgAb and TSH levels was 0.778 and 0.756,respectively,with a combined predicted AUC of 0.889.The AUC predicted by the combination of the two indicators was obviously higher than that predicted by a single indicator (Zcombination-TgAb=2.200,Zcombination-TSH=1.950,P=0.028,0.046),the sensitivity and specificity of the combined prediction of the two were 76.81% and 94.81%,respectively.Conclusion Serum TgAb and TSH levels in DTC patients are obviously upregulated,and there is a certain correlation between changes in TgAb and TSH levels and clinical pathological features.The combination of the two has high predictive value for postoperative metastasis in patients.

Key words: differentiated thyroid cancer; thyroid globulin antibody; thyroid stimulating hormone; clinical pathological features; postoperative metastasis

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[2] 朱旭阳;朱学锋. 乳腺癌改良根治术后负压引流管的改良应用[J]. 临床外科杂志, 2016, 24(11): 867 .
[3] 易凡;尚玉强;夏家红;等. 重症瓣膜病患者围手术期营养支持治疗体会[J]. 临床外科杂志, 2016, 24(12): 912 .
[4] 张华园;高峰;董军等. 颅内多发脑膜瘤一例[J]. 临床外科杂志, 2016, 24(4): 319 .
[5] 冯勋强. 改良Devine治疗小儿隐匿性阴茎158例分析[J]. 临床外科杂志, 2016, 24(5): 379 -0 .
[6] 金祺;阮文枫;赵欣宇等. Buck技术结合钉棒系统治疗青少年峡部裂性腰椎滑脱一例[J]. 临床外科杂志, 2016, 24(5): 347 -0 .
[7] 姜军 . 加速康复外科理念在金陵术围手术期的应用——肠道预康复治疗 [J]. 临床外科杂志, 2016, 24(6): 422 .
[8] 霍黎生;孙龙 . TSTstarr+术治疗女性出口梗阻型便秘 [J]. 临床外科杂志, 2016, 24(6): 470 .
[9] 曹子昂. 食管癌根治性放疗失败后的挽救性手术[J]. 临床外科杂志, 2016, 24(7): 540 .
[10] 谭黎杰;沈亚新. 微创食管切除术——复旦大学附属中山医院技术与经验[J]. 临床外科杂志, 2016, 24(7): 557 .